Effect of regulatory T cells on promoting apoptosis of t lymphocyte and its regulatory mechanism in sepsis

Journal of Interferon and Cytokine Research

Volumn 35, Issue 12, 2015, Pages 969-980

  Luan, Ying Yi ^a   Yin, Cheng Fen ^a   Qin, Qing Hua ^a   Dong, Ning ^a   Zhu, Xiao Mei ^a   Sheng, Zhi Yong ^a   Zhang, Qing Hong ^a   Yao, Yong Ming ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROTEIN BCL 2; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; APOPTOSIS REGULATORY PROTEIN; BCL2L11 PROTEIN, HUMAN; BCL2L11 PROTEIN, MOUSE; CASPASE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; MEMBRANE PROTEIN; ONCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CECAL LIGATION AND PUNCTURE-INDUCED SEPSIS; CELL ACTIVITY; CELL ISOLATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FLOW CYTOMETRY; GENE EXPRESSION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PATHOGENESIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPHENOTYPING; METABOLISM; MICROBIOLOGY; MOUSE; PHENOTYPE; PHOSPHORYLATION; SEPSIS; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-LIKE PROTEIN 11; CASPASES; CTLA-4 ANTIGEN; CYTOCHROMES C; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNOMODULATION; IMMUNOPHENOTYPING; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE PROTEINS; MICE; PHENOTYPE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SEPSIS; SMAD2 PROTEIN; SMAD3 PROTEIN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84951758686     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2014.0235     Document Type: Article

References (46)

1. Bourguet CB, Boulay PL, Claing A, Lubell WD. 2014. Design and synthesis of novel azapeptide activators of apoptosis mediated by caspase-9 in cancer cells. Bioorg Med Chem Lett 24(15):3361-3365.
2. Caraci F, Battaglia G, Busceti C, Biagioni F, Mastroiacovo F, Bosco P, Drago F,Nicoletti F, SortinoMA, Copani A. 2008. TGF-beta 1 protects against Abeta-neurotoxicity via the phosphatidylinositol-3-kinase pathway. Neurobiol Dis 30(2):234-242.
3. Chen C, Lei W, Chen W, Zhong J, Gao X, Li B, Wang H, Huang C. 2014. Serum TGF-beta1 and SMAD3 levels are closely associated with coronary artery disease. BMC Cardiovasc Disord 14:18.
4. Deppong CM, Bricker TL, Rannals BD, Van Rooijen N, Hsieh CS, Green JM. 2013. CTLA4Ig inhibits effector T cells through regulatory T cells and TGF-beta. J Immunol 191(6): 3082-3089.
5. Floyd DH, Zhang Y, Dey BK, et al. 2014. Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim. PLoS One 9(5):e96239.
6. Gaarenstroom T, Hill CS. 2014. TGF-beta signaling to chromatin: how Smads regulate transcription during self-renewal and differentiation. Semin Cell Dev Biol 32:107-118.
7. Gao R, Lu Y, Xin YP, Zhang XH, Wang J, Li YP. 2006. The effects of different immunosuppressants on chronic allograft nephropathy by affecting the transforming growth factor-beta and Smads signal pathways. Transplant Proc 38(7):2154-2157.
8. Goel SA, Guo LW, Shi XD, Kundi R, Sovinski G, Seedial S, Liu B, Kent KC. 2013. Preferential secretion of collagen type 3 versus type 1 from adventitial fibroblasts stimulated by TGF-beta/Smad3-treated medial smooth muscle cells. Cell Signal 25(4):955-960.
9. Hanschen M, Tajima G, O'Leary F, Hoang K, Ikeda K, Lederer JA. 2012. Phospho-flow cytometry based analysis of differences in T cell receptor signaling between regulatory T cells and CD4+ T cells. J Immunol Methods 376(1-2):1-12.
10. Hattori Y, Takano K, Teramae H, Yamamoto S, Yokoo H, Matsuda N. 2010. Insights into sepsis therapeutic design based on the apoptotic death pathway. J Pharmacol Sci 114(4):354-365.
11. Hesse M, Piccirillo CA, Belkaid Y, Prufer J, Mentink-Kane M, Leusink M, Cheever AW, Shevach EM, Wynn TA. 2004. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 172(5):3157-3166.
12. Horbelt D, Denkis A, Knaus P. 2012. A portrait of transforming growth factor beta superfamily signalling: background matters. Int J Biochem Cell Biol 44(3):469-474.
13. Hotchkiss RS, Monneret G, Payen D. 2013. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13(12):862-874.
14. Hotchkiss RS, Swanson PE, Knudson CM, et al. 1999. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol 162(7):4148-4156.
15. Huang M, Liu C, Hu Y, Wang P, Ding M. 2014. Gammasecretase inhibitor DAPT prevents neuronal death and memory impairment in sepsis associated encephalopathy in septic rats. Chin Med J (Engl) 127(5):924-928.
16. Jones AE, Puskarich MA. 2014. The Surviving Sepsis Campaign guidelines 2012: update for emergency physicians. Ann Emerg Med 63(1):35-47.
17. Kumar G, Kumar N, Taneja A, et al. 2011. Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest 140(5): 1223-1231.
18. Luan YY, Dong N, Xie M, Xiao XZ, Yao YM. 2014. The significance and regulatory mechanisms of innate immune cells in the development of sepsis. J Interferon Cytokine Res 34(1):2-15.
19. Luan YY, Yao YM, Sheng ZY. 2012. Update on the immunological pathway of negative regulation in acute insults and sepsis. J Interferon Cytokine Res 32:288-298.
20. Luan YY, Yao YM, Xiao XZ, Sheng ZY. 2015. Insights into the apoptotic death of immune cells in sepsis. J Interferon Cytokine Res 35(1):17-22.
21. Maitra SR, Bhaduri S, El-Maghrabi MR, Shapiro MJ. 2005a. Inhibition of matrix metalloproteinase on hepatic transforming growth factor beta1 and caspase-3 activation in hemorrhage. Acad Emerg Med 12(9):797-803.
22. Maitra SR, Shapiro MJ, Bhaduri S, El-Maghrabi MR. 2005b. Effect of chemically modified tetracycline on transforming growth factor-beta1 and caspase-3 activation in liver of septic rats. Crit Care Med 33(7):1577-1581.
23. Maizels RM. 2005. Infections and allergy-helminths, hygiene and host immune regulation. Curr Opin Immunol 17(6):656-661.
24. Miller MM, Fogle JE, Ross P, Tompkins MB. 2013. Feline glycoprotein A repetitions predominant anchors transforming growth factor beta on the surface of activated CD4(+) CD25(+) regulatory T cells and mediates AIDS lentivirusinduced T cell immunodeficiency. AIDS Res Hum Retroviruses 29(4):641-651.
25. Miller MM, Petty CS, Tompkins MB, Fogle JE. 2014. CD4+ CD25+ T regulatory cells activated during feline immunodeficiency virus infection convert T helper cells into functional suppressors through a membrane-bound TGFbeta/GARP-mediated mechanism. Virol J 11:7.
26. Nakamura K, Kitani A, Strober W. 2001. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194(5):629-644.
27. Olson BM, Jankowska-Gan E, Becker JT, Vignali DA, Burlingham WJ, McNeel DG. 2012. Human prostate tumor antigenspecific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade. J Immunol 189(12):5590-5601.
28. Onyilagha C, Okwor I, Kuriakose S, Singh R, Uzonna J. 2014. Low-dose intradermal infection with trypanosoma congolense leads to expansion of regulatory T cells and enhanced susceptibility to reinfection. Infect Immun 82(3):1074-1083.
29. Penn JW, Grobbelaar AO, Rolfe KJ. 2012. The role of the TGFbeta family in wound healing, burns and scarring: a review. Int J Burns Trauma 2(1):18-28.
30. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. 2009. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4(1):31-36.
31. Schmierer B, Hill CS. 2007. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8(12):970-982.
32. Schwulst SJ, Muenzer JT, Peck-Palmer OM, Chang KC, Davis CG, McDonough JS, Osborne DF, Walton AH, Unsinger J, McDunn JE, Hotchkiss RS. 2008. Bim siRNA decreases lymphocyte apoptosis and improves survival in sepsis. Shock 30(2):127-134.
33. Souza HP, Lima-Salgado T, da Cruz Neto LM. 2010. Toll-like receptors in sepsis: a tale still being told. Endocr Metab Immune Disord Drug Targets 10(3):285-291.
34. Venet F, Pachot A, Debard AL, Bohe J, Bienvenu J, Lepape A, Powell WS, Monneret G. 2006. Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol 177(9):6540-6547.
35. Weber SU, Schewe JC, Lehmann LE, Müller S, Book M, Klaschik S, Hoeft A, Stüber F. 2008. Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis. Crit Care 12(5):R128.
36. Wen Q, Zhang X, Cai J, Yang PH. 2014. A novel strategy for real-time and in situ detection of cytochrome c and caspase-9 in Hela cells during apoptosis. Analyst 139(10):2499-2506.
37. Wichterman KA, Baue AE, Chaudry IH. 1980. Sepsis and septic shock-a review of laboratory models and a proposal. J Surg Res 29(2):189-201.
38. Winter E, Dal Pizzol C, Filippin-Monteiro FB, Brondani P, Silva AM, Silva AH, Bonacorso HG, Martins MA, Zanatta N, Creczynski-Pasa TB. 2014. Antitumoral activity of a trichloromethyl pyrimidine analogue: molecular cross-talk between intrinsic and extrinsic apoptosis. Chem Res Toxicol 27(6):1040-1049.
39. Wurstle ML, Laussmann MA, Rehm M. 2012. The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome. Exp Cell Res 318(11):1213-1220.
40. Xu F, Lin SH, Yang YZ, Guo R, Cao J, Liu Q. 2013. The effect of curcumin on sepsis-induced acute lung injury in a rat model through the inhibition of the TGF-beta1/SMAD3 pathway. Int Immunopharmacol 16(1):1-6.
41. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275(5303):1129-1132.
42. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB, Deng C. 1999. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 18(5):1280-1291.
43. Zhang Q, Qian FH, Liu H, Zhou LF, Huang M, Zhang XL, Yin KS. 2008. Expression of surface markers on peripheral CD4+CD25high T cells in patients with atopic asthma: role of inhaled corticosteroid. Chin Med J (Engl) 121(3):205-212.
44. Zhang Y, Yao YM, Huang LF, Dong N, Yu Y, Sheng ZY. 2011. The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression. J Interferon Cytokine Res 31(2):249-257.
45. Zhao TT, Zhang HJ1, Lu XG, Huang XR, Zhang WK, Wang H, Lan HY, Li P. 2014. Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-beta/Smad3 signaling. PLoS One 9(3):e90807.
46. Zhu J, Wang J, Sheng Y, Zou Y, Bo L, Wang F, Lou J, Fan X, Bao R, Wu Y, Chen F, Deng X, Li J. 2012. Baicalin improves survival in a murine model of polymicrobial sepsis via suppressing inflammatory response and lymphocyte apoptosis. PLoS One 7(5):e35523.